Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03215667 · ClinicalTrials.gov registry record · NA
Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites
A NA study, sponsored by Sunstar Americas.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03215667 is a NA study that was terminated before completion, run by Sunstar Americas. The registered enrollment target is 9 participants.
The verdict
NCT03215667, a NA study, was terminated before completion, sponsored by Sunstar Americas.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Purpose of the single arm study is to clinically and histologically evaluate alloplastic in-situ hardening, moldable beta-tricalcium phosphate(TCP) bone graft material and polylactide membrane in alveolar ridge preservation following extraction of non-molar teeth with non-containable extraction sockets.
Interventions
- DEVICE easy-graft CLASSIC (beta-Tricalcium Phosphate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-11-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03215667
The ClinicalTrials.gov registry entry for NCT03215667 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sunstar Americas, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which easy-graft CLASSIC (beta-Tricalcium Phosphate) is the first listed.
NCT03215667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03215667 about?
NCT03215667 is a clinical study titled "Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites". Purpose of the single arm study is to clinically and histologically evaluate alloplastic in-situ hardening, moldable beta-tricalcium phosphate(TCP) bone graft material and polylactide membrane in alveolar ridge preservation following extraction of non-molar teeth with non-containable extraction sock...
What is the current status of trial NCT03215667?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2017-08-01. Estimated completion is 2019-11-03.
What interventions are being tested in trial NCT03215667?
The interventions under investigation include: easy-graft CLASSIC (beta-Tricalcium Phosphate) (DEVICE).
Who is sponsoring clinical trial NCT03215667?
This trial is sponsored by Sunstar Americas, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.